[go: up one dir, main page]

SE8502865D0 - Naphtoxazine, ihre herstellung und verwendung - Google Patents

Naphtoxazine, ihre herstellung und verwendung

Info

Publication number
SE8502865D0
SE8502865D0 SE8502865A SE8502865A SE8502865D0 SE 8502865 D0 SE8502865 D0 SE 8502865D0 SE 8502865 A SE8502865 A SE 8502865A SE 8502865 A SE8502865 A SE 8502865A SE 8502865 D0 SE8502865 D0 SE 8502865D0
Authority
SE
Sweden
Prior art keywords
naphtoxazine
repair
psychostimulating
oxazines
naphth
Prior art date
Application number
SE8502865A
Other languages
English (en)
Other versions
SE465428B (sv
SE8502865L (sv
Inventor
J Nozulak
R K A Giger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8502865D0 publication Critical patent/SE8502865D0/sv
Publication of SE8502865L publication Critical patent/SE8502865L/sv
Publication of SE465428B publication Critical patent/SE465428B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00Compounds containing azido groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE8502865A 1984-06-12 1985-06-10 Naftoxaziner, deras framstaellning och anvaendning SE465428B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3421729 1984-06-12
DE3508263 1985-03-08

Publications (3)

Publication Number Publication Date
SE8502865D0 true SE8502865D0 (sv) 1985-06-10
SE8502865L SE8502865L (sv) 1985-12-13
SE465428B SE465428B (sv) 1991-09-09

Family

ID=25822036

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8502865A SE465428B (sv) 1984-06-12 1985-06-10 Naftoxaziner, deras framstaellning och anvaendning

Country Status (28)

Country Link
US (1) US4656167A (sv)
JP (1) JPS611676A (sv)
AT (1) AT394717B (sv)
AU (1) AU582751B2 (sv)
BE (1) BE902600A (sv)
CA (1) CA1285561C (sv)
CH (1) CH666031A5 (sv)
CY (1) CY1581A (sv)
DE (1) DE3520104C2 (sv)
DK (1) DK172306B1 (sv)
ES (1) ES8704469A1 (sv)
FI (1) FI86301C (sv)
FR (1) FR2565586B1 (sv)
GB (1) GB2160200B (sv)
GR (1) GR851418B (sv)
HK (1) HK11891A (sv)
HU (1) HU193979B (sv)
IE (1) IE58398B1 (sv)
IL (1) IL75468A (sv)
IT (1) IT1200079B (sv)
LU (1) LU85941A1 (sv)
MY (1) MY102059A (sv)
NL (1) NL194166C (sv)
NZ (1) NZ212358A (sv)
PH (1) PH23666A (sv)
PT (1) PT80634B (sv)
SE (1) SE465428B (sv)
SG (1) SG9691G (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8616669D0 (en) * 1986-07-09 1986-08-13 Merk Sharpe & Dohme Ltd Pharmaceutical compositions
US5071875A (en) * 1989-09-25 1991-12-10 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
HU214591B (hu) * 1989-12-14 1998-04-28 Novartis Ag. Eljárás egy naftoxazinszármazék malonátsójának és az ilyen hatóanyagot tartalmazó gyógyszerkészítmények előállítására
DE4329776A1 (de) * 1993-09-03 1995-03-09 Sandoz Ag Naphthoxazine, ihre Herstellung und Verwendung
TW357143B (en) * 1995-07-07 1999-05-01 Novartis Ag Benzo[g]quinoline derivatives
JP2011525893A (ja) * 2008-06-27 2011-09-29 ハー・ルンドベック・アクチエゼルスカベット 新規のフェノールアミン類およびカテコールアミン類ならびにそのプロドラッグ

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2194421B1 (sv) * 1972-08-03 1975-10-17 Cerpha
AU521527B2 (en) * 1979-09-12 1982-04-08 Dow Chemical Company, The Dehydrohalogenation of (polyhaloalkyl) benzenes
US4368201A (en) * 1981-07-20 1983-01-11 Usv Pharmaceutical Corporation Tetrahydronaphthoxazoles
US4420480A (en) * 1981-11-20 1983-12-13 Merck & Co., Inc. Hexahydronaphth[1,2-b]-1,4-oxazines
CA1204745A (en) * 1981-11-20 1986-05-20 Merck Co. Hexahydronaphth (1,2-b) -1,4 -oxazines
DE4003262A1 (de) * 1990-02-03 1991-08-08 Sandoz Ag Neues naphthoxazin, seine herstellung und verwendung

Also Published As

Publication number Publication date
FR2565586B1 (fr) 1989-09-15
ES544074A0 (es) 1987-04-01
GR851418B (sv) 1985-11-25
FI86301C (sv) 1992-08-10
DE3520104A1 (de) 1985-12-12
AT394717B (de) 1992-06-10
GB2160200B (en) 1988-03-16
ATA172385A (de) 1991-11-15
HUT39438A (en) 1986-09-29
PT80634A (en) 1985-07-01
FI852325A0 (fi) 1985-06-11
JPS611676A (ja) 1986-01-07
CY1581A (en) 1992-04-03
IT1200079B (it) 1989-01-05
IL75468A (en) 1989-05-15
IL75468A0 (en) 1985-10-31
BE902600A (fr) 1985-12-06
AU582751B2 (en) 1989-04-13
DK259185D0 (da) 1985-06-10
IE851437L (en) 1985-12-12
SE465428B (sv) 1991-09-09
LU85941A1 (fr) 1986-01-24
GB8514636D0 (en) 1985-07-10
HK11891A (en) 1991-02-22
PH23666A (en) 1989-09-27
HU193979B (en) 1987-12-28
MY102059A (en) 1992-03-31
DK259185A (da) 1985-12-13
DK172306B1 (da) 1998-03-09
FR2565586A1 (fr) 1985-12-13
NL194166C (nl) 2001-08-03
PT80634B (pt) 1987-10-20
ES8704469A1 (es) 1987-04-01
DE3520104C2 (de) 1997-01-23
SE8502865L (sv) 1985-12-13
IE58398B1 (en) 1993-09-08
AU4345885A (en) 1985-12-19
CA1285561C (en) 1991-07-02
JPH0576472B2 (sv) 1993-10-22
US4656167A (en) 1987-04-07
CH666031A5 (de) 1988-06-30
NZ212358A (en) 1989-01-27
FI852325L (fi) 1985-12-13
NL194166B (nl) 2001-04-02
IT8548195A0 (it) 1985-06-11
GB2160200A (en) 1985-12-18
SG9691G (en) 1991-04-05
FI86301B (fi) 1992-04-30
NL8501526A (nl) 1986-01-02

Similar Documents

Publication Publication Date Title
DE3768076D1 (de) Gefaerbte hydrogele und ihre herstellung.
DE3674906D1 (de) Selbstklemmende medizinische prothese und ihre herstellung.
DE3768922D1 (de) Anthrapyridon-verbindungen, ihre herstellung und ihre verwendung.
DE69015418D1 (de) Energieversorgung.
ATE71095T1 (de) Azolylmethyloxirane - ihre herstellung und verwendung als pflanzenschutzmittel.
DE3684948D1 (de) Imidderivate, ihre herstellung und anwendung.
DE3777366D1 (de) 2,3-dihydro-cumaron-derivate, ihre herstellung und verwendung.
DE3668891D1 (de) Benzothiazolone, ihre herstellung und anwendung.
ATE63110T1 (de) Farblose ketimine, ihre herstellung und ihre verwendung als vernetzungsmittel.
DE69017080D1 (de) VHF-Gleichstrom-Gleichstrom-Leistungsversorgung.
FI853220A7 (sv) Aminoalkoxibensopyranoner som antipsykotiska och anxiolytiska ämnen.
AR241082A1 (es) Nuevos derivados de pirazol utiles como agentes herbicidas, las composiciones herbicidas que los contienen y los procedimientos para producir estos derivados de pirazol".
DE3774718D1 (de) Benzothiazolylazolidine und ihre herstellung und verwendung.
DE3689919D1 (de) Polyfluorisoxazolamine, ihre Herstellung und Anwendung.
DE3586224D1 (de) 3-carbonyl-1-aminoalkyl-1h-indole, verwendbar als analgetika und ihre herstellung.
PT85396A (de) Neue 1,4-benzodiazepine ihre herstellung und verwendung
SE8502865D0 (sv) Naphtoxazine, ihre herstellung und verwendung
DE3762879D1 (de) Polysulfurierte olefin-zusammensetzungen, ihre herstellung und ihre verwendung als schmiermittelzusaetze.
DE59708084D1 (de) Herstellung von trifluoroacetylfluorid
ATE45739T1 (de) Indolophenanthridine, ihre herstellung und verwendung.
ATE45164T1 (de) Steroido(3,2-c>-pyrazole, als antiandrogene und ihre herstellung.
DE3767107D1 (de) Astigmatismus-generator.
DE69022955D1 (de) Leistungszufuhr.
ATE96142T1 (de) Triglyceridquartaerammonium-verbindungen, ihre herstellung und anwendung.
ATE132500T1 (de) 24r-scymnol, herstellung und verwendung

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8502865-2

Format of ref document f/p: F

NUG Patent has lapsed